Celgene Corp. buy melinda
Start price
28.08.10
/
50%
€20.35
Target price
28.02.11
€25.00
Performance (%)
-4.90%
End price
28.02.11
€19.35
Summary
This prediction ended on 28.02.11 with a price of €19.35. With a performance of -4.90%, the BUY prediction for Celgene Corp. by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% | 61.658% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% | 104.644% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% | 51.355% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% | 66.527% |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
biopharmazeutisches
Celgene und filialles Biopharma Unternehmen in der Discovery-Prozess, Krebs und entzündliche Erkrankungen des Immunsystems beteiligt
(Laufzeit überschritten)